ACTIVE SUBSTANCE / INN

OMIDENEPAG ISOPROPYL

Brand name(s): OMLONTI
FDA LISTED
PRESCRIPTION
NDA215092
ACTIVE SUBSTANCE
Omidenepag Isopropyl
REGULATORS
FDA
SPONSORS / MAH
OCUVEX THERAP
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OMLONTINDA215092OCUVEX THERAPPrescription

FULL INTELLIGENCE ON OMIDENEPAG ISOPROPYL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →